Top healthcare companies by net margin
Pick a margin type to sort, or use a wider screen to sort by any column header. Click a column header to re-order rows. Company names link to each ticker's profile page.
| # | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | Novo Nordisk (NVO) | 81.8% | 45.3% | 56.7% | 37.2% | 9.4% | Healthcare | ||
| 2 | Vertex Pharmaceuticals (VRTX) | 86.3% | 39.0% | 44.0% | 35.4% | 30.3% | Healthcare | ||
| 3 | Eli Lilly (LLY) | 83.5% | 45.9% | 46.3% | 35.0% | 18.8% | Healthcare | ||
| 4 | Gilead Sciences (GILD) | 79.4% | 38.3% | 47.1% | 31.0% | 34.4% | Healthcare | ||
| 5 | Regeneron Pharmaceuticals (REGN) | 84.5% | 24.3% | 38.5% | 29.6% | 27.9% | Healthcare | ||
| 6 | Intuitive Surgical (ISRG) | 66.7% | 31.3% | 40.8% | 28.4% | 29.2% | Healthcare | ||
| 7 | Zoetis (ZTS) | 70.8% | 37.6% | 42.4% | 27.8% | 22.5% | Healthcare | ||
| 8 | Incyte (INCY) | 92.6% | 31.6% | 35.1% | 27.7% | 33.0% | Healthcare | ||
| 9 | ResMed (RMD) | 61.7% | 34.3% | 39.5% | 27.4% | 31.6% | Healthcare | ||
| 10 | IDEXX Laboratories (IDXX) | 62.1% | 31.6% | 35.1% | 24.6% | 24.3% | Healthcare | ||
| 11 | Johnson & Johnson (JNJ) | 71.3% | 26.5% | 30.0% | 21.6% | 18.9% | Healthcare | ||
| 12 | Mettler Toledo (MTD) | 57.8% | 28.0% | 30.6% | 21.4% | 19.4% | Healthcare | ||
| 13 | Amgen (AMGN) | 71.5% | 31.6% | 44.8% | 20.9% | 23.1% | Healthcare | ||
| 14 | Agilent Technologies (A) | 53.0% | 21.5% | 27.1% | 19.6% | 17.4% | Healthcare | ||
| 15 | Illumina (ILMN) | 67.1% | 20.9% | 32.6% | 19.4% | 22.5% | Healthcare | ||
| 16 | DexCom (DXCM) | 61.8% | 21.4% | 30.6% | 19.3% | 29.7% | Healthcare | ||
| 17 | Boston Scientific (BSX) | 71.2% | 21.6% | 22.5% | 17.5% | 16.4% | Healthcare | ||
| 18 | Solventum (SOLV) | 53.7% | 25.5% | 33.3% | 17.3% | -2.5% | Healthcare | ||
| 19 | AstraZeneca (AZN) | 79.4% | 22.7% | 33.5% | 17.0% | 14.3% | Healthcare | ||
| 20 | West Pharmaceutical Services (WST) | 36.8% | 20.6% | 24.8% | 17.0% | 13.1% | Healthcare | ||
| 21 | Danaher (DHR) | 58.5% | 20.4% | 25.6% | 15.9% | 21.8% | Healthcare | ||
| 22 | Edwards Lifesciences (EW) | 78.0% | 28.1% | 23.6% | 15.4% | 16.7% | Healthcare | ||
| 23 | Thermo Fisher Scientific (TMO) | 40.4% | 17.7% | 23.6% | 15.1% | 15.8% | Healthcare | ||
| 24 | Bristol-Myers Squibb (BMY) | 68.7% | 25.7% | 28.4% | 15.0% | 24.6% | Healthcare | ||
| 25 | Merck & Co. (MRK) | 75.9% | 27.6% | 28.6% | 13.6% | 21.5% | Healthcare | ||
| 26 | Alnylam Pharmaceuticals (ALNY) | 80.9% | 17.5% | 21.6% | 13.5% | 15.0% | Healthcare | ||
| 27 | Stryker (SYK) | 63.7% | 21.3% | 24.4% | 13.2% | 18.1% | Healthcare | ||
| 28 | Medtronic (MDT) | 65.0% | 17.8% | 26.7% | 13.2% | 14.9% | Healthcare | ||
| 29 | STERIS (STE) | 44.2% | 18.6% | 30.8% | 13.2% | 16.4% | Healthcare | ||
| 30 | Waters Corporation (WAT) | 55.0% | 17.1% | 24.5% | 11.9% | 7.0% | Healthcare | ||
| 31 | Pfizer (PFE) | 69.3% | 23.4% | 26.5% | 11.8% | 15.0% | Healthcare | ||
| 32 | Abbott Laboratories (ABT) | 56.8% | 17.0% | 21.3% | 11.6% | 18.7% | Healthcare | ||
| 33 | Insulet (PODD) | 71.0% | 17.5% | 19.8% | 10.4% | 14.2% | Healthcare | ||
| 34 | Align Technology (ALGN) | 68.2% | 13.3% | 19.0% | 10.0% | 18.3% | Healthcare | ||
| 35 | AptarGroup (ATR) | 29.0% | 13.0% | 21.6% | 10.0% | 8.4% | Healthcare | ||
| 36 | Quest Diagnostics (DGX) | 33.1% | 14.1% | 17.4% | 9.2% | 10.6% | Healthcare | ||
| 37 | Zimmer Biomet Holdings (ZBH) | 70.0% | 15.6% | 26.2% | 9.1% | 21.8% | Healthcare | ||
| 38 | Bio-Techne (TECH) | 65.0% | 12.7% | 21.3% | 9.0% | 22.3% | Healthcare | ||
| 39 | HCA Healthcare (HCA) | 28.4% | 15.5% | 20.3% | 8.8% | 7.7% | Healthcare | ||
| 40 | Universal Health Services (UHS) | 51.4% | 11.4% | 15.6% | 8.4% | 4.9% | Healthcare | ||
| 41 | Biogen (BIIB) | 67.7% | 12.8% | 16.8% | 8.4% | 29.8% | Healthcare | ||
| 42 | Revvity (RVTY) | 51.4% | 12.4% | 26.6% | 8.3% | 17.0% | Healthcare | ||
| 43 | IQVIA (IQV) | 26.2% | 13.6% | 20.8% | 8.1% | 17.6% | Healthcare | ||
| 44 | GE HealthCare (GEHC) | 42.9% | 12.7% | 16.4% | 7.9% | 4.4% | Healthcare | ||
| 45 | Labcorp Holdings (LH) | 27.8% | 11.0% | 14.6% | 6.7% | 9.8% | Healthcare | ||
| 46 | AbbVie (ABBV) | 70.7% | 27.6% | 26.9% | 5.8% | 33.2% | Healthcare | ||
| 47 | DaVita (DVA) | 31.1% | 15.0% | 19.5% | 5.6% | 10.8% | Healthcare | ||
| 48 | Cooper Companies (COO) | 64.4% | 11.8% | 20.5% | 5.6% | 13.5% | Healthcare | ||
| 49 | Becton, Dickinson and (BDX) | 46.5% | 10.6% | 21.9% | 5.3% | 14.7% | Healthcare | ||
| 50 | UnitedHealth Group (UNH) | 22.5% | 4.8% | 5.7% | 3.1% | 5.2% | Healthcare | ||
| 51 | Henry Schein (HSIC) | 29.7% | 5.6% | 7.5% | 3.0% | 3.2% | Healthcare | ||
| 52 | Elevance Health (ELV) | 39.0% | 3.5% | 4.0% | 2.5% | 3.1% | Healthcare | ||
| 53 | Cigna (CI) | 9.3% | 3.4% | 4.4% | 2.3% | 2.8% | Healthcare | ||
| 54 | McKesson (MCK) | 3.6% | 1.6% | 1.7% | 1.2% | 1.5% | Healthcare | ||
| 55 | Humana (HUM) | 13.7% | 1.4% | 2.1% | 0.9% | -0.3% | Healthcare | ||
| 56 | Cencora (COR) | 3.5% | 1.3% | 1.5% | 0.8% | 0.5% | Healthcare | ||
| 57 | CVS Health (CVS) | 13.9% | 1.5% | 2.7% | 0.7% | 1.8% | Healthcare | ||
| 58 | Cardinal Health (CAH) | 3.7% | 0.9% | 1.2% | 0.6% | 1.8% | Healthcare | ||
| 59 | Molina Healthcare (MOH) | 34.6% | 0.7% | 0.8% | -0.0% | 0.6% | Healthcare | ||
| 60 | Viatris (VTRS) | 34.4% | 1.0% | 17.6% | -2.0% | 11.7% | Healthcare | ||
| 61 | Centene (CNC) | 16.1% | -2.8% | -1.5% | -2.6% | 4.6% | Healthcare | ||
| 62 | Charles River (CRL) | 31.9% | 11.8% | 7.2% | -4.6% | 9.7% | Healthcare | ||
| 63 | Teladoc Health (TDOC) | 69.0% | -7.5% | -2.9% | -7.1% | 9.0% | Healthcare | ||
| 64 | Baxter International (BAX) | 30.1% | -2.7% | 6.5% | -9.7% | 6.3% | Healthcare | ||
| 65 | Tempus AI (TEM) | 69.6% | -18.1% | -9.9% | -22.2% | -15.9% | Healthcare | ||
| 66 | Moderna (MRNA) | -13.9% | -153.3% | -129.7% | -143.6% | -71.1% | Healthcare |
- 1Novo Nordisk (NVO)37.2%
- 3Eli Lilly (LLY)35.0%
- 4Gilead Sciences (GILD)31.0%
- 7Zoetis (ZTS)27.8%
- 8Incyte (INCY)27.7%
- 9ResMed (RMD)27.4%
- 10IDEXX Laboratories (IDXX)24.6%
- 11Johnson & Johnson (JNJ)21.6%
- 12Mettler Toledo (MTD)21.4%
- 13Amgen (AMGN)20.9%
- 14Agilent Technologies (A)19.6%
- 15Illumina (ILMN)19.4%
- 16DexCom (DXCM)19.3%
- 17Boston Scientific (BSX)17.5%
- 18Solventum (SOLV)17.3%
- 19AstraZeneca (AZN)17.0%
- 21Danaher (DHR)15.9%
- 22Edwards Lifesciences (EW)15.4%
- 24Bristol-Myers Squibb (BMY)15.0%
- 25Merck & Co. (MRK)13.6%
- 27Stryker (SYK)13.2%
- 28Medtronic (MDT)13.2%
- 29STERIS (STE)13.2%
- 30Waters Corporation (WAT)11.9%
- 31Pfizer (PFE)11.8%
- 32Abbott Laboratories (ABT)11.6%
- 33Insulet (PODD)10.4%
- 34Align Technology (ALGN)10.0%
- 35AptarGroup (ATR)10.0%
- 36Quest Diagnostics (DGX)9.2%
- 38Bio-Techne (TECH)9.0%
- 39HCA Healthcare (HCA)8.8%
- 41Biogen (BIIB)8.4%
- 42Revvity (RVTY)8.3%
- 43IQVIA (IQV)8.1%
- 44GE HealthCare (GEHC)7.9%
- 45Labcorp Holdings (LH)6.7%
- 46AbbVie (ABBV)5.8%
- 47DaVita (DVA)5.6%
- 48Cooper Companies (COO)5.6%
- 50UnitedHealth Group (UNH)3.1%
- 51Henry Schein (HSIC)3.0%
- 52Elevance Health (ELV)2.5%
- 53Cigna (CI)2.3%
- 54McKesson (MCK)1.2%
- 55Humana (HUM)0.9%
- 56Cencora (COR)0.8%
- 57CVS Health (CVS)0.7%
- 58Cardinal Health (CAH)0.6%
- 59Molina Healthcare (MOH)-0.0%
- 60Viatris (VTRS)-2.0%
- 61Centene (CNC)-2.6%
- 62Charles River (CRL)-4.6%
- 63Teladoc Health (TDOC)-7.1%
- 64Baxter International (BAX)-9.7%
- 65Tempus AI (TEM)-22.2%
- 66Moderna (MRNA)-143.6%
Sorted by Net Margin · Ranks (#) are among the loaded leaderboard rows, not worldwide.
How TTM margins are measured
Margins divide a profitability line by trailing-twelve-month revenue, expressed as a percentage. Each column on this page measures a different layer of the income statement — gross strips only direct production costs; operating subtracts overhead, R&D and D&A; EBITDA adds D&A back to operating; net subtracts interest and taxes; FCF replaces accrual profit with operating cash flow minus capex. Together they describe where a business actually makes its money.
Margins make capital-light franchises directly comparable to capital-heavy ones — a software filer with a 35% operating margin runs a different model than a global retailer at 6%. To compare absolute scale instead of percentages see the revenue ranking and net income ranking. Non-USD filers are ranked on USD-translated TTM lines so peers stay comparable. Rankings USD translation methodology · IFRS IAS 21 (official)
Other rankings
Explore more company and market rankings
Income Statement
Cash Flow
Balance Sheet
Operations
Capital Return
Market Cap
Stock Performance
Global